Medicare Enrolled
Dr. Lakhbinder Dhanda, M.D.
Optician · Valencia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dhanda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dhanda?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dhanda
Dr. Lakhbinder Dhanda is an optician specialist in Valencia, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dhanda performed 2,251 Medicare services across 1,380 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dhanda received a total of $7,783 from 39 pharmaceutical and/or device companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dhanda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in CA
$7,783 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,251
Medicare services
Top 34% in CA for optician
1,380
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~118 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
810 | $70 | $130 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
304 | $144 | $165 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
297 | $68 | $210 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
145 | $102 | $235 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
133 | $97 | $160 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
97 | $70 | $310 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
94 | $149 | $410 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $48 | $110 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
85 | $158 | $210 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
81 | $7 | $45 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
31 | $168 | $210 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
20 | $15 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $78 | $195 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $141 | $210 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $111 | $360 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
12 | $182 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,783
Total received (2018-2024)
Avg $1,112/year across 7 years
Top 17% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
334
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,783 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,101
2023
$794
2022
$1,267
2021
$1,088
2020
$700
2019
$1,306
2018
$1,527
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$491
Phathom Pharmaceuticals, Inc.
$128
Boehringer Ingelheim Pharmaceuticals, Inc.
$117
Novo Nordisk Inc
$48
Otsuka America Pharmaceutical, Inc.
$43
GlaxoSmithKline, LLC.
$42
Amgen Inc.
$37
Janssen Pharmaceuticals, Inc
$35
Novartis Pharmaceuticals Corporation
$32
Abbott Laboratories
$28
Lilly USA, LLC
$24
Xeris Pharmaceuticals, Inc.
$22
Radius Health, Inc.
$21
ABBVIE INC.
$19
PFIZER INC.
$15
Top 3 companies account for 66.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,685
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,146
GlaxoSmithKline, LLC.
$1,040
Janssen Pharmaceuticals, Inc
$442
Novartis Pharmaceuticals Corporation
$379
PFIZER INC.
$369
Merck Sharp & Dohme Corporation
$311
Lilly USA, LLC
$272
Amgen Inc.
$251
Ironwood Pharmaceuticals, Inc
$206
AbbVie Inc.
$134
Phathom Pharmaceuticals, Inc.
$128
Allergan, Inc.
$125
ARBOR PHARMACEUTICALS, INC.
$122
E.R. Squibb & Sons, L.L.C.
$100
Amarin Pharma Inc.
$95
Abbott Laboratories
$94
Bayer HealthCare Pharmaceuticals Inc.
$93
Novo Nordisk Inc
$85
Radius Health, Inc.
$77
Arbor Pharmaceuticals, Inc.
$75
Otsuka America Pharmaceutical, Inc.
$56
SANOFI-AVENTIS U.S. LLC
$54
ABBVIE INC.
$53
Merck Sharp & Dohme LLC
$45
AbbVie, Inc.
$40
Philips Electronics North America Corporation
$38
Mylan Specialty L.P.
$37
Eisai Inc.
$34
GENZYME CORPORATION
$29
La Jolla Pharmaceutical Company
$28
Exact Sciences Corporation
$25
Xeris Pharmaceuticals, Inc.
$22
Astellas Pharma US Inc
$21
Teva Pharmaceuticals USA, Inc.
$19
IBSA Pharma Inc.
$16
Alnylam Pharmaceuticals Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Top 3 companies account for 49.8% of all-time payments
Associated products mentioned in payments ›
(6479) Spectral CT 7500 · AIRSUPRA · AJOVY · ANDEXXA · ANORO · ANORO ELLIPTA · Aimovig · BELSOMRA · BREO · BREZTRI · BRILINTA · BYDUREON · CERDELGA · CHANTIX · Cologuard Collection Kit · DIFICID · DUZALLO · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Lite system · GIAPREZA · GVOKE HYPOPEN · Horizant · INVOKANA · Infinity DBS Pulse Generators · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · MOUNJARO · MYRBETRIQ · ONPATTRO · Otezla · Ozempic · PAXLOVID · PRADAXA · Prolia · REXULTI · Repatha · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · SYNTHROID · Synthroid · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tirosint · Tymlos · UBRELVY · Uloric · VOQUEZNA · Vascepa · XARELTO · XIFAXAN · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
536
Per 100K population
5.4
County median income
$87,760
Nearest hospital
HENRY MAYO NEWHALL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dhanda is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dhanda experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Dhanda performed 810 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dhanda receive payments from pharmaceutical companies?
Yes. Dr. Dhanda received a total of $7,783 from 39 companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dhanda's costs compare to other opticians in Valencia?
Dr. Dhanda's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dhanda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Valencia
Browse opticians in Valencia ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology